Discovery Methodology of Novel Conotoxins from Conus Species

Mar Drugs. 2018 Oct 30;16(11):417. doi: 10.3390/md16110417.

Abstract

Cone snail venoms provide an ideal resource for neuropharmacological tools and drug candidates discovery, which have become a research hotspot in neuroscience and new drug development. More than 1,000,000 natural peptides are produced by cone snails, but less than 0.1% of the estimated conotoxins has been characterized to date. Hence, the discovery of novel conotoxins from the huge conotoxin resources with high-throughput and sensitive methods becomes a crucial key for the conotoxin-based drug development. In this review, we introduce the discovery methodology of new conotoxins from various Conus species. It focuses on obtaining full N- to C-terminal sequences, regardless of disulfide bond connectivity through crude venom purification, conotoxin precusor gene cloning, venom duct transcriptomics, venom proteomics and multi-omic methods. The protocols, advantages, disadvantages, and developments of different approaches during the last decade are summarized and the promising prospects are discussed as well.

Keywords: crude venom purification; discovery; gene cloning; methodology; multi-omics; novel conotoxins; proteomics; transcriptomics.

Publication types

  • Review

MeSH terms

  • Animals
  • Cloning, Molecular / methods
  • Conotoxins / chemistry
  • Conotoxins / isolation & purification
  • Conotoxins / metabolism
  • Conotoxins / pharmacology*
  • Conus Snail / metabolism*
  • Drug Discovery / methods
  • High-Throughput Screening Assays / methods*
  • Neurotoxins / chemistry
  • Neurotoxins / isolation & purification
  • Neurotoxins / metabolism
  • Neurotoxins / pharmacology*
  • Proteomics / methods

Substances

  • Conotoxins
  • Neurotoxins